We identify, support, and invest early stage companies, to commercialise and scale within the NHS and other healthcare delivery systems globally.
There is an incredible pool of innovative ventures with unexpressed potential and by selectively investing in these companies we endeavour to provide our investors with early winners and favourable returns.
The European footprint of this project will attract expert capital and non-dilutive capital to further support our chosen technologies in their journeys.
The international proposition on offer will be unique in its genre and will attract additional and better flow of candidates to choose from.
The diversity of the investor bases will give the scale to make this first launch a success and pave the road for larger and life-changing projects.